Found: 1750
Select item for more details and to access through your institution.
Comparative immunogenicity assessment of biosimilar natalizumab to its reference medicine: a matching immunogenicity profile.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1414304
- By:
- Publication type:
- Article
Development and validation of a candidate reference method for serum cortisol by isotope dilution liquid chromatography-tandem mass spectrometry combined with dextran sulfate-Mg2+ precipitation.
- Published in:
- Analytical & Bioanalytical Chemistry, 2020, v. 412, n. 6, p. 1325, doi. 10.1007/s00216-019-02356-2
- By:
- Publication type:
- Article
Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination.
- Published in:
- Histochemistry & Cell Biology, 2022, v. 158, n. 1, p. 15, doi. 10.1007/s00418-022-02096-y
- By:
- Publication type:
- Article
Exposure-response analysis of endoxifen serum concentrations in early-breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recommendations on vitamin D needs in multiple sclerosis from the MS Society of Canada.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recovery and relapse from severe acute malnutrition after treatment: a prospective, observational cohort trial in Pakistan.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The pleiotropic effects of statins in rheumatoid arthritis.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 7, p. 910, doi. 10.1093/jpp/rgad024
- By:
- Publication type:
- Article
Association of Increased Homocysteine Levels with Impaired Folate Metabolism and Vitamin B Deficiency in Early-Onset Multiple Sclerosis.
- Published in:
- Biochemistry (00062979), 2024, v. 89, n. 3, p. 562, doi. 10.1134/S0006297924030143
- By:
- Publication type:
- Article
SARS-CoV2 Infection in a Multiple Sclerosis Patient Treated with Natalizumab - A Case Presentation.
- Published in:
- Acta Marisiensis. Seria Medica, 2020, v. 66, n. 3, p. 110, doi. 10.2478/amma-2020-0022
- By:
- Publication type:
- Article
The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series.
- Published in:
- Children, 2022, v. 9, n. 11, p. 1698, doi. 10.3390/children9111698
- By:
- Publication type:
- Article
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2023, v. 9, n. 4, p. 1, doi. 10.1177/20552173231204466
- By:
- Publication type:
- Article
Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, p. 1, doi. 10.1177/20552173211070752
- By:
- Publication type:
- Article
The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211066588
- By:
- Publication type:
- Article
The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 4, p. 1, doi. 10.1177/20552173211066588
- By:
- Publication type:
- Article
Patient and treatment characteristics and safety outcomes of patients with relapsing-remitting multiple sclerosis treated with natalizumab in Greece: Results from the multicenter, 5-year prospective observational study 'TOPICS greece'.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211035803
- By:
- Publication type:
- Article
Patient and treatment characteristics and safety outcomes of patients with relapsing-remitting multiple sclerosis treated with natalizumab in Greece: Results from the multicenter, 5-year prospective observational study 'TOPICS greece'.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 3, p. 1, doi. 10.1177/20552173211035803
- By:
- Publication type:
- Article
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211013831
- By:
- Publication type:
- Article
Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211004634
- By:
- Publication type:
- Article
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 2, p. 1, doi. 10.1177/20552173211013831
- By:
- Publication type:
- Article
Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 2, p. 1, doi. 10.1177/20552173211004634
- By:
- Publication type:
- Article
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Human caudate nucleus exhibits a highly complex ganglioside pattern as revealed by high-resolution multistage Orbitrap MS.
- Published in:
- Journal of Carbohydrate Chemistry, 2019, v. 38, n. 9, p. 531, doi. 10.1080/07328303.2019.1669632
- By:
- Publication type:
- Article
Platelet transfusions in haploidentical haematopoietic stem cell allograft candidates: Protecting HLA‐A and HLA‐B antigens through eplet analysis.
- Published in:
- HLA: Immune Response Genetics, 2024, v. 103, n. 3, p. 1, doi. 10.1111/tan.15438
- By:
- Publication type:
- Article
Brain Activation Changes During Balance- and Attention-Demanding Tasks in Middle- and Older-Aged Adults With Multiple Sclerosis.
- Published in:
- Motor Control, 2019, v. 23, n. 4, p. 498, doi. 10.1123/mc.2018-0044
- By:
- Publication type:
- Article
Correlation of -475 IL-2 Promoter Gene Polymorphisms and the Levels of Serum IL-2 on the Risk of Multiple Sclerosis.
- Published in:
- Reports of Biochemistry & Molecular Biology, 2022, v. 11, n. 1, p. 83, doi. 10.52547/rbmb.11.1.83
- By:
- Publication type:
- Article
Analysis of Micro-RNA-144 Expression Profile in Patients with Multiple Sclerosis in Comparison with Healthy Individuals.
- Published in:
- Reports of Biochemistry & Molecular Biology, 2021, v. 10, n. 3, p. 396, doi. 10.52547/rbmb.10.3.396
- By:
- Publication type:
- Article
Association of HLA-DRA and IL2RA Polymorphisms with the Severity and Relapses Rate of Multiple Sclerosis in an Iranian Population.
- Published in:
- Reports of Biochemistry & Molecular Biology, 2020, v. 9, n. 2, p. 129, doi. 10.29252/rbmb.9.2.129
- By:
- Publication type:
- Article
A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes.
- Published in:
- Alexandria Journal of Veterinary Sciences, 2020, v. 66, n. 2, p. 30, doi. 10.5455/ajvs.125962
- By:
- Publication type:
- Article
Progressive multifocal fibrosing neuropathy: description of a novel disease.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01341-8
- By:
- Publication type:
- Article
Patients' and caregivers' maximum acceptable risk of death for non‐curative gene therapy to treat Duchenne muscular dystrophy.
- Published in:
- Molecular Genetics & Genomic Medicine, 2021, v. 9, n. 5, p. 1, doi. 10.1002/mgg3.1664
- By:
- Publication type:
- Article
Description of combined ARHSP/JALS phenotype in some patients with SPG11 mutations.
- Published in:
- Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 7, p. 1, doi. 10.1002/mgg3.1240
- By:
- Publication type:
- Article
Profound intellectual disability caused by homozygous TRAPPC9 pathogenic variant in a man from Malta.
- Published in:
- Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 5, p. 1, doi. 10.1002/mgg3.1211
- By:
- Publication type:
- Article
Spastic paraplegia as the predominant phenotype in a cohort of Chinese patients with adrenoleukodystrophy.
- Published in:
- Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1002/mgg3.1065
- By:
- Publication type:
- Article
B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07336-8
- By:
- Publication type:
- Article
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02665-6
- By:
- Publication type:
- Article
Seasonal variability of serum 25-hydroxyvitamin D on multiple sclerosis onset.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00344-0
- By:
- Publication type:
- Article
Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91912-x
- By:
- Publication type:
- Article
Double inversion recovery in evaluation of multiple sclerosis: a narrative review.
- Published in:
- Revista Latinoamericana de Hipertension, 2019, v. 14, n. 3, p. 325
- By:
- Publication type:
- Article
Hyper-reflective foci changes in RRMS under natalizumab therapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1421755
- By:
- Publication type:
- Article
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1416464
- By:
- Publication type:
- Article
Bioavailable central nervous system disease-modifying therapies for multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1290666
- By:
- Publication type:
- Article
Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1242508
- By:
- Publication type:
- Article
Impact of Obesity on Lumbar Puncture Outcomes in Adults with Acute Lymphoblastic Leukemia and Lymphoma: Experience at an Academic Reference Center.
- Published in:
- International Journal of Hematology-Oncology & Stem Cell Research, 2019, v. 13, n. 3, p. 146
- By:
- Publication type:
- Article
Exceptional Responder to Immunotherapy: A Rare Case of Post- HSCT DLBCL Relapse Responding to Nivolumab.
- Published in:
- International Journal of Hematology-Oncology & Stem Cell Research, 2019, v. 13, n. 2, p. 68
- By:
- Publication type:
- Article
Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options.
- Published in:
- Medical Decision Making, 2020, v. 40, n. 2, p. 198, doi. 10.1177/0272989X19897944
- By:
- Publication type:
- Article
Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22265-2
- By:
- Publication type:
- Article
The tumor therapy landscape of synthetic lethality.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21544-2
- By:
- Publication type:
- Article
A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20594-2
- By:
- Publication type:
- Article
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 1, p. 120, doi. 10.3390/pharmaceutics16010120
- By:
- Publication type:
- Article